DK0708768T3 - Trisubstituerede imidazoler, der har multiple terapeutiske egenskaber - Google Patents
Trisubstituerede imidazoler, der har multiple terapeutiske egenskaberInfo
- Publication number
- DK0708768T3 DK0708768T3 DK94923503T DK94923503T DK0708768T3 DK 0708768 T3 DK0708768 T3 DK 0708768T3 DK 94923503 T DK94923503 T DK 94923503T DK 94923503 T DK94923503 T DK 94923503T DK 0708768 T3 DK0708768 T3 DK 0708768T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic properties
- multiple therapeutic
- trisubstituted imidazoles
- trisubstituted
- imidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9273393A | 1993-07-16 | 1993-07-16 | |
PCT/US1994/007969 WO1995002591A1 (en) | 1993-07-16 | 1994-07-15 | Tri-substituted imidazoles having multiple therapeutic properties |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0708768T3 true DK0708768T3 (da) | 2003-08-04 |
Family
ID=22234840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94923503T DK0708768T3 (da) | 1993-07-16 | 1994-07-15 | Trisubstituerede imidazoler, der har multiple terapeutiske egenskaber |
Country Status (31)
Country | Link |
---|---|
EP (5) | EP0708768B1 (da) |
JP (4) | JPH09500137A (da) |
CN (2) | CN1050126C (da) |
AP (1) | AP484A (da) |
AT (2) | ATE236896T1 (da) |
AU (1) | AU694130C (da) |
BR (2) | BR9407079A (da) |
CA (1) | CA2167311A1 (da) |
CZ (1) | CZ11996A3 (da) |
DE (2) | DE69434316T2 (da) |
DK (1) | DK0708768T3 (da) |
DZ (1) | DZ1798A1 (da) |
ES (2) | ES2197167T3 (da) |
FI (1) | FI960177A0 (da) |
HK (4) | HK1049657A1 (da) |
HU (1) | HUT75313A (da) |
IL (2) | IL110296A (da) |
MA (1) | MA23270A1 (da) |
MY (1) | MY116478A (da) |
NO (4) | NO316881B1 (da) |
NZ (2) | NZ329994A (da) |
PL (4) | PL181705B1 (da) |
PT (1) | PT708768E (da) |
RU (1) | RU2140918C1 (da) |
SG (1) | SG52368A1 (da) |
SI (1) | SI0708768T1 (da) |
SK (1) | SK282342B6 (da) |
TW (1) | TW330934B (da) |
UA (1) | UA63875C2 (da) |
WO (1) | WO1995002591A1 (da) |
ZA (1) | ZA945193B (da) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3857751A (en) * | 1971-11-15 | 1974-12-31 | Tufdura Ltd | Composite sheet capable of withstanding impingement by particulate materials |
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
US5670527A (en) * | 1993-07-16 | 1997-09-23 | Smithkline Beecham Corporation | Pyridyl imidazole compounds and compositions |
US6613789B2 (en) | 1994-07-28 | 2003-09-02 | G. D. Searle & Co. | Heterocyclo-substituted imidazoles for the treatment of inflammation |
US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
GB9500580D0 (en) * | 1995-01-12 | 1995-03-01 | Merck Sharp & Dohme | Therapeutic agents |
MX9705296A (es) * | 1995-01-12 | 1997-10-31 | Smithkline Beecham Corp | Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia. |
EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
US6369068B1 (en) | 1995-06-07 | 2002-04-09 | Smithkline Beecham Corporation | Amino substituted pyrimidine containing compounds |
US5739143A (en) * | 1995-06-07 | 1998-04-14 | Smithkline Beecham Corporation | Imidazole compounds and compositions |
US5658903A (en) * | 1995-06-07 | 1997-08-19 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US5717100A (en) * | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
US6083949A (en) * | 1995-10-06 | 2000-07-04 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
DE19540027A1 (de) * | 1995-10-27 | 1997-04-30 | Gruenenthal Gmbh | Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe |
ZA9610687B (en) * | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
NZ327044A (en) * | 1996-01-11 | 2000-01-28 | Smithkline Beecham Corp | Substituted imidazole compounds |
AP9700912A0 (en) * | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
JP2001508395A (ja) * | 1996-01-11 | 2001-06-26 | スミスクライン・ビーチャム・コーポレイション | 新規シクロアルキル置換イミダゾール |
US6372741B1 (en) * | 1996-03-08 | 2002-04-16 | Smithkline Beecham Corporation | Use of CSAID™ compounds as inhibitors of angiogenesis |
JP2000507558A (ja) * | 1996-03-25 | 2000-06-20 | スミスクライン・ビーチャム・コーポレイション | Cns損傷についての新規な治療 |
WO1997047618A1 (en) * | 1996-06-10 | 1997-12-18 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
WO1998007425A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US6608060B1 (en) | 1996-12-18 | 2003-08-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US5945418A (en) * | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
US6187799B1 (en) | 1997-05-23 | 2001-02-13 | Onyx Pharmaceuticals | Inhibition of raf kinase activity using aryl ureas |
JP2002504909A (ja) | 1997-06-13 | 2002-02-12 | スミスクライン・ビーチャム・コーポレイション | 新規な置換ピラゾールおよびピラゾリン化合物 |
EP0994870A4 (en) | 1997-06-19 | 2002-10-23 | Smithkline Beecham | NEW IMIDAZOLE COMPOUNDS SUBSTITUTED BY AN ARYLOXYREST |
WO1999001452A1 (en) | 1997-07-02 | 1999-01-14 | Smithkline Beecham Corporation | Novel cycloalkyl substituted imidazoles |
US6489325B1 (en) | 1998-07-01 | 2002-12-03 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
TW517055B (en) * | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
US6362193B1 (en) | 1997-10-08 | 2002-03-26 | Smithkline Beecham Corporation | Cycloalkenyl substituted compounds |
EP1021173A1 (en) * | 1997-10-10 | 2000-07-26 | Imperial College Innovations Limited | Use of csaid?tm compounds for the management of uterine contractions |
JP3337992B2 (ja) * | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | 5−置換ピコリン酸化合物及びその製造方法 |
WO1999032121A1 (en) | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
GB9809869D0 (en) * | 1998-05-09 | 1998-07-08 | Medical Res Council | Inhibition of protein kinases |
TR200003472T2 (tr) | 1998-05-22 | 2001-09-21 | Smithkline Beecham Corporation | Yeni 2-alkil ikameli imidazol bileşikler |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
AU4273099A (en) | 1998-06-24 | 2000-01-10 | Medical Research Council | Polypeptides, polynucleotides and uses thereof |
WO2000001688A1 (fr) * | 1998-07-02 | 2000-01-13 | Sankyo Company, Limited | Composes heteroaryle a cinq elements |
US6207687B1 (en) * | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
EP1112070B1 (en) * | 1998-08-20 | 2004-05-12 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
AU1909200A (en) | 1998-11-04 | 2000-05-22 | Smithkline Beecham Corporation | Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
US6239279B1 (en) | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
US20020065296A1 (en) | 1999-01-13 | 2002-05-30 | Bayer Corporation | Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
JP2002534468A (ja) | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
ATE305787T1 (de) | 1999-11-23 | 2005-10-15 | Smithkline Beecham Corp | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren |
DE60020595T2 (de) | 1999-11-23 | 2006-03-16 | Smithkline Beecham Corp. | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren |
AU1781601A (en) | 1999-11-23 | 2001-06-04 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
US6627647B1 (en) * | 2000-03-23 | 2003-09-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
FR2823751B1 (fr) * | 2001-04-24 | 2003-05-23 | Oreal | Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires |
FR2823747B1 (fr) * | 2001-04-24 | 2003-05-23 | Oreal | Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires |
WO2002094267A1 (fr) * | 2001-05-24 | 2002-11-28 | Sankyo Company, Limited | Preparation pharmaceutique pour prevenir ou traiter l'arthrite |
EP2324825A1 (en) | 2002-02-11 | 2011-05-25 | Bayer Healthcare LLC | Aryl ureas with angiogenesis inhibiting activity |
PT1580188E (pt) | 2002-02-11 | 2012-01-25 | Bayer Healthcare Llc | Aril-ureias como inibidores de cinases |
RU2217196C2 (ru) * | 2002-02-28 | 2003-11-27 | Небольсин Владимир Евгеньевич | Способ индукции дифференцировки клеток |
CN101597262A (zh) * | 2002-03-05 | 2009-12-09 | 特兰斯泰克制药公司 | 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物 |
DE60334016D1 (de) | 2002-11-05 | 2010-10-14 | Glaxo Group Ltd | Antibakterielle mittel |
ATE366108T1 (de) | 2003-05-20 | 2007-07-15 | Bayer Pharmaceuticals Corp | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
NZ580384A (en) | 2003-07-23 | 2011-03-31 | Bayer Pharmaceuticals Corp | 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions |
CA2599879C (en) * | 2005-03-11 | 2013-07-02 | Zenyaku Kogyo Kabushikikaisha | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
TWI517850B (zh) | 2009-09-30 | 2016-01-21 | Vtv治療有限責任公司 | 經取代之咪唑衍生物及其使用方法 |
EP2493876B1 (en) * | 2009-10-28 | 2014-02-12 | Pfizer Inc | Imidazole derivatives as casein kinase inhibitors |
CN104387301B (zh) * | 2014-11-11 | 2016-05-04 | 常州大学 | 一种2-氟-4-甲基苯磺酰甲基异腈的合成方法 |
CN113350353A (zh) | 2015-03-23 | 2021-09-07 | 墨尔本大学 | 呼吸性疾病的治疗 |
AU2018262108A1 (en) * | 2017-05-03 | 2019-11-21 | The University Of Melbourne | Compounds for the treatment of respiratory diseases |
CN114112812A (zh) * | 2021-10-29 | 2022-03-01 | 华北电力大学 | 相变颗粒测试装置、固-液相变机理可视化实验台及方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3707475A (en) * | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
US3929807A (en) * | 1971-05-10 | 1975-12-30 | Ciba Geigy Corp | 2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles |
WO1992010190A1 (en) * | 1990-12-13 | 1992-06-25 | Smithkline Beecham Corporation | Novel csaids |
EP0563286A4 (en) * | 1990-12-13 | 1995-01-11 | Smithkline Beecham Corp | Novel csaids |
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
-
1994
- 1994-07-12 IL IL11029694A patent/IL110296A/xx not_active IP Right Cessation
- 1994-07-13 AP APAP/P/1994/000654A patent/AP484A/en active
- 1994-07-13 DZ DZ940081A patent/DZ1798A1/fr active
- 1994-07-14 MY MYPI94001844A patent/MY116478A/en unknown
- 1994-07-14 MA MA23584A patent/MA23270A1/fr unknown
- 1994-07-15 EP EP94923503A patent/EP0708768B1/en not_active Expired - Lifetime
- 1994-07-15 ZA ZA945193A patent/ZA945193B/xx unknown
- 1994-07-15 HU HU9503855A patent/HUT75313A/hu unknown
- 1994-07-15 ES ES94923503T patent/ES2197167T3/es not_active Expired - Lifetime
- 1994-07-15 PT PT94923503T patent/PT708768E/pt unknown
- 1994-07-15 EP EP02076582A patent/EP1227092A3/en not_active Withdrawn
- 1994-07-15 DE DE69434316T patent/DE69434316T2/de not_active Expired - Fee Related
- 1994-07-15 BR BR9407079A patent/BR9407079A/pt not_active Application Discontinuation
- 1994-07-15 JP JP7504744A patent/JPH09500137A/ja active Pending
- 1994-07-15 PL PL94312614A patent/PL181705B1/pl unknown
- 1994-07-15 AT AT94923503T patent/ATE236896T1/de not_active IP Right Cessation
- 1994-07-15 EP EP02079534A patent/EP1291346B1/en not_active Expired - Lifetime
- 1994-07-15 EP EP02076580A patent/EP1227091A3/en not_active Withdrawn
- 1994-07-15 NZ NZ329994A patent/NZ329994A/xx unknown
- 1994-07-15 AU AU73354/94A patent/AU694130C/en not_active Ceased
- 1994-07-15 AT AT02079534T patent/ATE291576T1/de not_active IP Right Cessation
- 1994-07-15 CN CN94193161A patent/CN1050126C/zh not_active Expired - Fee Related
- 1994-07-15 WO PCT/US1994/007969 patent/WO1995002591A1/en not_active Application Discontinuation
- 1994-07-15 SG SG1996003561A patent/SG52368A1/en unknown
- 1994-07-15 EP EP02076581A patent/EP1229035A1/en not_active Withdrawn
- 1994-07-15 DE DE69432463T patent/DE69432463T2/de not_active Expired - Fee Related
- 1994-07-15 PL PL94332408A patent/PL181721B1/pl unknown
- 1994-07-15 PL PL94332405A patent/PL181723B1/pl unknown
- 1994-07-15 UA UA96010110A patent/UA63875C2/uk unknown
- 1994-07-15 SK SK47-96A patent/SK282342B6/sk unknown
- 1994-07-15 CA CA002167311A patent/CA2167311A1/en not_active Abandoned
- 1994-07-15 ES ES02079534T patent/ES2237650T3/es not_active Expired - Lifetime
- 1994-07-15 NZ NZ269457A patent/NZ269457A/en unknown
- 1994-07-15 DK DK94923503T patent/DK0708768T3/da active
- 1994-07-15 PL PL94332406A patent/PL181694B1/pl unknown
- 1994-07-15 RU RU96103386/04A patent/RU2140918C1/ru not_active IP Right Cessation
- 1994-07-15 CZ CZ96119A patent/CZ11996A3/cs unknown
- 1994-07-15 SI SI9430449T patent/SI0708768T1/xx unknown
- 1994-10-04 TW TW083109192A patent/TW330934B/zh active
-
1996
- 1996-01-15 FI FI960177A patent/FI960177A0/fi unknown
- 1996-01-15 NO NO960173A patent/NO316881B1/no not_active IP Right Cessation
-
1997
- 1997-05-13 BR BR1100546-7A patent/BR1100546A/pt active IP Right Grant
-
1998
- 1998-05-04 IL IL12431898A patent/IL124318A0/xx unknown
- 1998-06-17 CN CN98115012A patent/CN1218801A/zh active Pending
- 1998-12-16 HK HK03100345.9A patent/HK1049657A1/zh unknown
- 1998-12-16 HK HK98113635A patent/HK1012392A1/xx not_active IP Right Cessation
- 1998-12-16 HK HK03100350.1A patent/HK1049659A1/zh unknown
- 1998-12-16 HK HK03100349.5A patent/HK1049658A1/zh unknown
-
2001
- 2001-02-19 NO NO20010838A patent/NO20010838D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010837A patent/NO20010837D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010839A patent/NO20010839D0/no not_active Application Discontinuation
-
2003
- 2003-12-10 JP JP2003412029A patent/JP2004099622A/ja active Pending
- 2003-12-10 JP JP2003412020A patent/JP2004083600A/ja active Pending
- 2003-12-10 JP JP2003412024A patent/JP2004149541A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0708768T3 (da) | Trisubstituerede imidazoler, der har multiple terapeutiske egenskaber | |
ITBO910182A1 (it) | Apparecchiatura per trattamenti di emodiafiltrazione. | |
FI960389A0 (fi) | Tietoliikennejärjestelmä | |
FI931747A0 (fi) | Reflexkropp, isynnerhet foer vaegmarkeringar | |
FI960387A0 (fi) | Tietoliikennejärjestelmä | |
FI922508A0 (fi) | Pao en vattenhaltig vaetska baserad tvaettmedelskomposition med lineaer viskoelastisitet, avsedd foer auto- matiska diskmaskiner. | |
FI931825A (fi) | Hydraulisk tryck- och draganordning, speciellt foer jaernvaegsskenor | |
FI955523A (fi) | 1-(2-bentsimidatsolyyli)-1,5-diatsasyklo-oksataaniyhdisteet | |
FI934317A (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
IT1284729B1 (it) | Apparecchiatura per trattamenti di dialisi. | |
FI923542A (fi) | Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner | |
IT233705Y1 (it) | Cuffia. | |
IT1270847B (it) | Apparecchiatura per trattamenti di emodiafiltrazione. | |
ITBO930227A1 (it) | Apparecchiatura per trattamenti di dialisi. | |
FI930961A0 (fi) | Matstation foer koettboskap, saerskilt svin | |
FR2706048B1 (fr) | Collimateur facilement contrôlable. | |
IT1274839B (it) | Apparecchiatura perfezionata per trattamenti di dialisi. | |
FI266U1 (fi) | Kapningsanordning foer aemnesbana, saosom en pappersbana | |
FI935129A0 (fi) | Tvaovaoningsgodsvagn, saerskilt foer biltransport | |
FI922500A0 (fi) | Pao en vattenhaltig vaetska baserad tvaettmedelskomposition med lineaer viskoelastisitet, avsedd foer automatiska diskmaskiner. | |
FI933095A0 (fi) | Nyckel, saerskilt staellbar nyckel | |
ITBO930229A0 (it) | Apparecchiatura di tipo perfezionato per trattamenti di emodiafiltra- zione. | |
FI147U1 (fi) | Anordning foer fuktning av pao landsvaegar utspridda, halhet foerebyggandematerial | |
ES1022927Y (es) | Hilo para aplicaciones medicas. | |
ES1023811Y (es) | Aposito terapeutico. |